GI & Endoscopy

A study published in Microbiome examined bidirectional brain-gut microbiome interactions, gut microbial composition and if there are correlations between gut microbial measures and structural brain signatures in irritable bowel syndrome patients.

The American Gastroenterological Association released a new care pathway for managing U.S.-based patients with hepatitis C viral infections.

Here are seven updates on GI companies from the past week.

Here are five updates on GI companies from the past week.

Mark Eisner, MD, is a gastroenterologist at Tampa-based Florida Medical Clinic.

OrphoMed completed a $39 million round of series A financing for the development of its irritable bowel syndrome with diarrhea drug ORP-101.

Pittsfield, Mass.-based Berkshire Health System added Jacques Reichling, MD, to its medical staff, iBerkshires reports.

Minneapolis-based Minnesota Gastroenterology is expanding into Woodbury, Minn., the Woodbury Bulletin reports.

Eisai Co. presented the results of its phase III trial for its anticancer agent lenvatinib mesylate at the American Society of Clinical Oncology's annual meeting, June 2 to June 6 in Chicago.

Physicians Endoscopy purchased a minority stake in East Patchogue, N.Y.-based Great South Bay Endoscopy.